Status
Conditions
Treatments
About
The purpose of this study is to assess the effects of polyphenols from natural aronia juice on the immune system.
Therefore, the study aims to distinguish the effects of natural juices that are rich in phytonutrients such as polyphenols and carotenoids in healthy and depressive subjects in order to use the known positive effects of these food sources in the therapeutic setting.
The consumption of natural fruit juices that are rich in polyphenols and carotenoids mirror a model of vegetarian diet due to the increased micronutrient density derived from plant food. Results obtained here can be seen as preliminary explanation models for the beneficial effects of vegetarian diet.
It is hypothesized, that the consumption of naturally polyphenol rich aronia juice changes the expression of regulatory T cells, specific cells of the immune system that contribute to immunomodulation. Furthermore, beneficial changes in the gut microbiome, the metabolome and the nutritional status are expected in the studied groups.
The study was registered retrospectively (after start of recruitment) on Clinicaltrials.gov.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Socio-demographic criteria:
Confirmation of the study settings
receives of information on
signed declaration of consent
Subgroup of depressive patients:
diagnosis of depression according to the ICD-10 criteria for depression
diagnosed by an experienced psychiatrist
Subgroup of normal weight participants:
Subgroup of obese participants
Exclusion criteria
Formal criteria:
Health criteria
alcohol- or drug abuse
major cognitive deficits (which do not allow adequate testing)
patients which are currently in the locked ward of the clinic
acute or chronic diseases or infections within the previous two months
Digestive disorders
fructose intolerance
history of digestive diseases such as
treatment that may has influenced the microbiome
history of gastrointestinal surgery (other than appendectomy)
Pregnancy and period of breastfeeding
Primary purpose
Allocation
Interventional model
Masking
120 participants in 6 patient groups, including a placebo group
Loading...
Central trial contact
Sonja Lackner, Dr.; Sandra Holasek, Prof.
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal